LianMedical LIANY
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.98% | 22.92% | 41.80% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.81% | -2.18% | -24.82% | -- | -- |
| Operating Income | 9.81% | 2.18% | 24.82% | -- | -- |
| Income Before Tax | 23.74% | 19.18% | 34.62% | -- | -- |
| Income Tax Expenses | 185.85% | 120.69% | 121.95% | -- | -- |
| Earnings from Continuing Operations | 22.28% | 17.80% | 34.38% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.28% | 17.80% | 34.38% | -- | -- |
| EBIT | 9.81% | 2.18% | 24.82% | -- | -- |
| EBITDA | 10.19% | 2.62% | 25.14% | -- | -- |
| EPS Basic | 27.75% | 49.08% | 83.74% | -- | -- |
| Normalized Basic EPS | 28.43% | 49.66% | 83.54% | -- | -- |
| EPS Diluted | 27.75% | 49.08% | 83.74% | -- | -- |
| Normalized Diluted EPS | 28.43% | 49.66% | 83.54% | -- | -- |
| Average Basic Shares Outstanding | 7.67% | 38.36% | 92.73% | -- | -- |
| Average Diluted Shares Outstanding | 7.67% | 38.36% | 92.73% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |